Management of patients with hidradenitis suppurativa during the COVID-19 pandemic.

Montero-Vilchez, Trinidad; Martinez-Lopez, Antonio; Salvador-Rodriguez, Luis; Molina-Leyva, Alejandro; Arias-Santiago, Salvador

Montero-Vilchez, Trinidad; Martinez-Lopez, Antonio; Salvador-Rodriguez, Luis; Molina-Leyva, Alejandro; Arias-Santiago, Salvador.

Montero-Vilchez T; Department of Dermatology, Hospital Universitario Virgen de las Nieves, Granada, Spain.
Martinez-Lopez A; Department of Dermatology, Hospital Universitario Virgen de las Nieves, Granada, Spain.
Salvador-Rodriguez L; Instituto de Investigación Biosanitaria (ibs.Granada), Granada, Spain.
Molina-Leyva A; Department of Dermatology, Hospital Universitario Virgen de las Nieves, Granada, Spain.
Arias-Santiago S; Department of Dermatology, Hospital Universitario Virgen de las Nieves, Granada, Spain.

Dermatol Ther ; 33(6): e13875, 2020 11.

Article in English | MEDLINE | ID: covidwho-607998

Subject(s)

COVID-19/epidemiology; Hidradenitis Suppurativa/drug therapy; SARS-CoV-2; COVID-19/etiology; Hidradenitis Suppurativa/complications; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hidradenitis Suppurativa / SARS-CoV-2 / COVID-19 Type of study: Observational study Topics: Long Covid Limits: Humans Language: English Journal: Dermatol Ther Journal subject: Dermatology Year: 2020 Document Type: Article Affiliation country: Dth.13875

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google